Tusk Therapeutics presents data on to its anti-CD25 programme at AACR Annual Meeting 2018
Apr 18, 2018 20:00 HKT |  |
|
AACR annual meeting 2018: Nanobiotix presented preclinical data showing NBTXR3 nanoparticles can activate the cGAS-STING pathway
Apr 18, 2018 09:00 HKT |  |
|
Taiho Pharmaceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy
Apr 17, 2018 08:00 HKT |  |
|
The University of Texas MD Anderson Cancer Center and Nanobiotix have an Agreement to Run Immunotherapeutic Pre-clinical Research in Lung Cancer Combining NBTXR3 and Nivolumab
Apr 11, 2018 09:00 HKT | |
|
New compound could improve stroke patient recovery
Apr 10, 2018 17:30 HKT |  |
|
TANAKA Begins Sample Shipments of SKe-Lid Glass Lids Made of Quartz with AuSn for Deep Ultraviolet LEDs
Apr 03, 2018 00:00 HKT |  |
|
Nanobiotix 2017 Annual Results
Mar 30, 2018 22:10 HKT | |
|
Helsinn Healthcare S.A.: Winners of the inaugural Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced
Mar 28, 2018 21:50 HKT | |
|
Tusk Therapeutics to Present Data at AACR Annual Meeting 2018
Mar 28, 2018 14:00 HKT | |
|
PromarkerD Diagnostic Test Leader Officially Launched
Mar 20, 2018 05:00 HKT |  |
|
Bio-on launches Biodegradable Solution for the Controlled-release of Urea Fertilizers
Mar 14, 2018 15:15 HKT |  |
|
Singapore eDevelopment's Global BioLife confirms LB2 efficacy against Ebola
Mar 01, 2018 14:00 HKT |  |
|
Holista Group Company signs US$6M MOU to supply Low-GI Noodle Mix to Wing's of Canada
Feb 14, 2018 17:00 HKT |  |
|
Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services
Feb 12, 2018 06:00 HKT | |
|
Sanofi Delivers 2017 Business EPS in line with Guidance
Feb 07, 2018 15:00 HKT |  |
|
Nanobiotix Presents First Promising Data from Phase I/II Liver Cancers Trial of NBTXR3 at the American Society of Clinical Oncology Gastrointestinal Annual Meeting
Jan 22, 2018 15:00 HKT | |
|
Sanofi to Acquire Bioverativ for $11.6 Billion
Jan 22, 2018 14:00 HKT | |
|
Nanobiotix Partners with Providence Cancer Institute to run Immunotherapeutic Preclinical Research in Pancreatic Cancers
Jan 11, 2018 15:00 HKT | |
|
Nanobiotix: 2017 review and 2018 expected milestones
Dec 26, 2017 15:50 HKT | |
|
FDA approves Nanobiotix's first Immuno-Oncology trial
Dec 26, 2017 15:15 HKT | |
|